Serial Number | 88028436 |
Word Mark | NOVELLUS |
Filing Date | Friday, July 6, 2018 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 10, 2020 |
Registration Number | 6008685 |
Registration Date | Tuesday, March 10, 2020 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 18, 2019 |
Goods and Services | Biochemicals in the nature of synthetic RNA encoding natural or engineered nucleases, zinc-finger nucleases, meganucleases, nickases, and transcription activator-like effector nucleases for use in vivo and in vitro genetic engineering |
Goods and Services | Pharmaceuticals for treating human and veterinary non-infectious diseases in the nature of inflammatory diseases, infectious diseases, vitamin B12 deficiency, degenerative joint diseases, sensory organ diseases, hereditary diseases, namely, genetic diseases in the nature of chromosomal abnormalities, single gene defects, multifactorial and teratogenic conditions, idiopathic intracranial hypertension, aesthetic skin diseases, traumatic brain injury, psychological diseases and physiological diseases in the nature of heart disease; gene therapy products, namely, genetically engineered cells and tissues for medical purposes, specifically for transplant purposes; chemical reagents for medical and veterinary purposes; synthetic mRNA being nucleic acid sequences and chemical reagents for medical and veterinary purposes for correcting deficient or defective genes; cell therapy products, namely, pharmaceutical preparations for use in cell therapy for treatment of cancer; synthetic mRNA being nucleic acid sequences and related chemical reagents for medical and veterinary purposes for reprogramming cells; synthetic RNA encoding reprogramming factors, namely, pharmaceutical preparations for use in cell therapy for treatment of wounded skin, cancer, chromosomal abnormalities, single gene defects, multifactorial and teratogenic conditions, idiopathic intracranial hypertension, aesthetic skin diseases, traumatic brain injury, and heart disease; products in the nature of pharmaceutical preparations for use in cell therapy for converting non-pluripotent cells into pluripotent stem cells, with or without gene-editing, for treatment of wounded skin, cancer, chromosomal abnormalities, single gene defects, multifactorial and teratogenic conditions, idiopathic intracranial hypertension, aesthetic skin diseases, traumatic brain injury, and heart disease |
Goods and Services | Gene therapy technology in the nature of downloadable software for gene-editing that uses de novo-engineered gene-editing proteins expressed with synthetic mRNA; cell therapy products, namely, cell reprogramming technology in the nature of instruments for scientific laboratory research that use reprogramming factors expressed with synthetic mRNA, namely, cell-culture instruments in the nature of cell incubators, cell transfection instruments, and cell imaging instruments |
Goods and Services | Pharmaceutical research and development services; pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without mRNA engineering; pharmaceutical research and development services in the field of, gene editing, mRNA engineering, cell reprogramming and cell therapy development; scientific laboratory services, in the field of stem cell production; scientific laboratory services in the field of production of stem cells and converting non-pluripotent cells into pluripotent stem cells, with or without gene-editing; scientific laboratory services in the field of gene-editing |
Translation of Words in Mark | The wording "NOVELLUS" has no meaning in a foreign language. |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 19, 2019 |
Primary Code | 001 |
First Use Anywhere Date | Tuesday, October 1, 2019 |
First Use In Commerce Date | Tuesday, October 1, 2019 |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 4, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Monday, March 31, 2014 |
First Use In Commerce Date | Monday, March 31, 2014 |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 19, 2019 |
Primary Code | 009 |
First Use Anywhere Date | Friday, November 8, 2019 |
First Use In Commerce Date | Friday, November 8, 2019 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, February 4, 2020 |
Primary Code | 042 |
First Use Anywhere Date | Monday, March 31, 2014 |
First Use In Commerce Date | Monday, March 31, 2014 |
Party Name | Factor Bioscience LLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Cambridge, MA 02141 |
Party Name | Factor Bioscience LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Cambridge, MA 02141 |
Party Name | Factor Bioscience LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Cambridge, MA 02141 |
Event Date | Event Description |
Tuesday, March 10, 2020 | REGISTERED-PRINCIPAL REGISTER |
Friday, February 7, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Thursday, February 6, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Sunday, December 29, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, December 18, 2019 | USE AMENDMENT FILED |
Sunday, December 29, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, December 18, 2019 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, August 13, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 18, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 18, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, May 29, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, May 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, May 10, 2019 | EXAMINER'S AMENDMENT ENTERED |
Friday, May 10, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, May 10, 2019 | EXAMINERS AMENDMENT E-MAILED |
Friday, May 10, 2019 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, May 9, 2019 | EXAMINER'S AMENDMENT ENTERED |
Thursday, May 9, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, May 9, 2019 | EXAMINERS AMENDMENT E-MAILED |
Thursday, May 9, 2019 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, April 10, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, April 10, 2019 | FINAL REFUSAL E-MAILED |
Wednesday, April 10, 2019 | FINAL REFUSAL WRITTEN |
Tuesday, February 19, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, February 19, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, February 18, 2019 | ASSIGNED TO LIE |
Tuesday, February 12, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, October 27, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, October 27, 2018 | NON-FINAL ACTION E-MAILED |
Saturday, October 27, 2018 | NON-FINAL ACTION WRITTEN |
Thursday, October 25, 2018 | ASSIGNED TO EXAMINER |
Thursday, July 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, July 10, 2018 | NEW APPLICATION ENTERED IN TRAM |